Genetic Technologies
GENE
#10946
Rank
โ‚น0.35 B
Marketcap
โ‚น72.97
Share price
0.00%
Change (1 day)
-65.72%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.17 a decrease over its 2022 EPS that were of -โ‚น2.11.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.1750.65%
2022-โ‚น2.11-99.04%
2021-โ‚น218.76-46.67%
2020-โ‚น410.18-99.38%
2019-โ‚น65,62810809.09%
2018-โ‚น601.59-41.07%
2017-โ‚น1,021-18.37%
2016-โ‚น1,251-40.24%
2015-โ‚น2,093-53.41%
2014-โ‚น4,492-10.66%
2013-โ‚น5,02871.3%
2012-โ‚น2,935-622.73%
2011โ‚น561.49-108.8%
2010-โ‚น6,381-3.92%
2009-โ‚น6,64173.47%
2008-โ‚น3,82824.96%
2007-โ‚น3,064-10.93%
2006-โ‚น3,439-48.62%
2005-โ‚น6,694-8.31%
2004-โ‚น7,301
2003N/A-100%
2002-โ‚น4,533-9.36%
2001-โ‚น5,001

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,738N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น874.73N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น495.07N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,084N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น35.29N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น267.72N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น410.18N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,56,130N/A๐Ÿ‡บ๐Ÿ‡ธ USA